PATENT CLAIM ANALYSIS

Application Number: 16060234
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "392000"]

Abstract:
The present invention relates to the use of DBH inhibitors (e.g., disulfiram and Nepicastat), and pharmaceutical compositions thereof, for treating subjects with certain types of memory loss, for instance memory loss associated with a neurodegenerative disease, disorder, or condition, such as Alzheimer's Disease.

Claim (Index 46):
The method of any one of  claims 1 - 45 , wherein the titrated regimen is known in the medical arts and/or approved for a particular indication.

Metadata:
- Claim Count in Document: 25.0
- Percentile: 94.0
- Lexical Diversity: 1.28571
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12154907', '15757217', '15409775', '14099882', '14552298']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7503800431815749
- 35 USC 102 Novelty (BERT): 0.5198319318003078
- Combined Prediction Score: 0.7273252320434482
- Mean Citation Score: 182.174734
- Max Citation Score: 207.3275
- Similarity Product: 106.26598124265672

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test